Preserving cellular energy stores by inhibiting poly-ADP-ribosylation may represent a key neuroprotective strategy for the treatment of traumatic brain injury (TBI). However, poly-ADP-ribosylation may also serve beneficial roles after TBI by participating in the maintenance of genomic integrity, regulation of RNA transcription, and excitatory amino acid-mediated memory acquisition. These dichotomous roles likely depend upon the cellular compartment and specific poly-ADP-ribosylated protein targets, warranting rigorous examination in experimental models, prior to implementation of clinical treatment strategies targeting poly- ADP-ribosylation after acute brain injury. Our hypotheses are that: 1) acutely after brain injury, supra- physiologic poly-ADP-ribosylation is detrimental because it disturbs cellular energetics by depletion of NAD and ATP, leading to mitochondrial failure and cell death, and 2) chronically after brain injury, physiologic poly-ADP-ribosylation is beneficial because it facilitates DNA repair, regulates RNA transcription, and is important in processes related to memory.
Our specific aims are to: 1) Further explore the organelle-specific effects of novel poly(ADP-ribose) polymerase (PARP) inhibitors after experimental TBI in vivo using specific PARP inhibitors, transgenic mice, and a targeted proteomics approach that identifies PARP substrates in nuclear, mitochondrial, and cytosolic compartments, 2) Further explore the neuroprotective and chronic effects of novel PARP inhibitors after TBI using a comprehensive battery of neuropathologic outcome tests evaluating structural and functional brain damage, and 3) Test the hypothesis that PARPactivation occurs in humans after TBI by applying a novel ELISA-based method for quantifying poly(ADP-ribose)-modified proteins in cerebrospinal fluid from humans with TBI, and identifying PARP substrates using a targeted proteomic approach, to establish a clinical basis for further development and a means for therapeutic drug monitoring of PARP inhibitors. TBI strikes without warning and is a major cause of morbidity and mortality in humans. Energy failure contributes to morbidity and mortality with only a few nonspecific therapies available.
Specific aims will be integrated to completely define cellular proteins post-translationally modified by poly- ADP-ribosylation, to better define the role of PARPin normalcy and disease, and to aid in the development of novel cell compartment-specific agents targeting energy failure-induced cell death after TBI.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS030318-16
Application #
7657395
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
16
Fiscal Year
2008
Total Cost
$148,749
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Markos, Steven M; Failla, Michelle D; Ritter, Anne C et al. (2017) Genetic Variation in the Vesicular Monoamine Transporter: Preliminary Associations With Cognitive Outcomes After Severe Traumatic Brain Injury. J Head Trauma Rehabil 32:E24-E34
Ikonomovic, Milos D; Mi, Zhiping; Abrahamson, Eric E (2017) Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders. Ageing Res Rev 34:51-63
Jackson, Edwin K; Kotermanski, Shawn E; Menshikova, Elizabeth V et al. (2017) Adenosine production by brain cells. J Neurochem 141:676-693
Kumar, Raj G; Rubin, Jonathan E; Berger, Rachel P et al. (2016) Principal components derived from CSF inflammatory profiles predict outcome in survivors after severe traumatic brain injury. Brain Behav Immun 53:183-193
Santarsieri, M; Kumar, R G; Kochanek, P M et al. (2015) Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury. Brain Behav Immun 45:15-27
Janata, Andreas; Magnet, Ingrid A M; Uray, Thomas et al. (2014) Regional TNF? mapping in the brain reveals the striatum as a neuroinflammatory target after ventricular fibrillation cardiac arrest in rats. Resuscitation 85:694-701
Santarsieri, Martina; Niyonkuru, Christian; McCullough, Emily H et al. (2014) Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury. J Neurotrauma 31:699-712
Gandy, Sam; Ikonomovic, Milos D; Mitsis, Effie et al. (2014) Chronic traumatic encephalopathy: clinical-biomarker correlations and current concepts in pathogenesis. Mol Neurodegener 9:37
Alexander, Sheila A; Ren, Dianxu; Gunn, Scott R et al. (2014) Interleukin 6 and apolipoprotein E as predictors of acute brain dysfunction and survival in critical care patients. Am J Crit Care 23:49-57
Yan, Hong Q; Shin, Samuel S; Ma, Xiecheng et al. (2014) Differential effect of traumatic brain injury on the nuclear factor of activated T Cells C3 and C4 isoforms in the rat hippocampus. Brain Res 1548:63-72

Showing the most recent 10 out of 71 publications